SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Stock Swap

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: needawin who wrote (13612)5/5/1998 12:14:00 AM
From: Jeffrey S. Mitchell  Read Replies (2) of 17305
 
Needawin, sometimes being outside a sector actually works to your advantage. In the case of ENMD I knew nothing about them until I read the NY Times article and thus reacted like one of the mass-media induced herd I guess.

For example, when PLSIA was granted an FDA license for their teeth-whitening laser, the stock barely moved. Then the Wall Street Journal did a story about them and the stock went from 6 to 18 the next day. With ENMD, everything reported in the press was a rehash of what was reported by the company in Nature. In other words, don't underestimate the power of the mass-media!

As for other biotech stocks, I am on record here for being a fan of RIBI. I don't like the management, just the product. Unlike ENMD,RIBI has already completed Phase III trials on humans and should within the next few days to months get approval in Canada for a cancer vaccine-- which would be a first anywhere in the world. SGP (Schering Plough) has already signed a contract with them worth $30M for worldwide rights (outside of Canada).

- Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext